HUANG Cheng, LIN Gen, LI Yang-si. RAS Mutation Underlies a Rational Polytherapy Strategy in EML4-ALK-Positive Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(1): 36-40. DOI: 10.12019/j.issn.1671-5144.2016.01.010
|
Citation:
|
HUANG Cheng, LIN Gen, LI Yang-si. RAS Mutation Underlies a Rational Polytherapy Strategy in EML4-ALK-Positive Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(1): 36-40. DOI: 10.12019/j.issn.1671-5144.2016.01.010
|
HUANG Cheng, LIN Gen, LI Yang-si. RAS Mutation Underlies a Rational Polytherapy Strategy in EML4-ALK-Positive Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(1): 36-40. DOI: 10.12019/j.issn.1671-5144.2016.01.010
|
Citation:
|
HUANG Cheng, LIN Gen, LI Yang-si. RAS Mutation Underlies a Rational Polytherapy Strategy in EML4-ALK-Positive Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(1): 36-40. DOI: 10.12019/j.issn.1671-5144.2016.01.010
|
DownLoad: